Wire Stories
EpimAb Biotherapeutics Strengthens Scientific Advisory Board with Addition of Andrew X. Zhu
SHANGHAI & SUZHOU, China–(BUSINESS WIRE)–EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibodies, today announced the appointment of Andrew X....